Editor-in-Chief: Godefridus J. Peters
Journal Rank: Impact Factor 2023: 4.6 - Q1 (ONCOLOGY); CiteScore 2023: 6.6 - Q1 [Pharmacology(medical)]
Submission to first decision: 10 days

Cancer Drug Resistance

Interview with Professor David A. Gewirtz: Exploring Breakthroughs in Cancer Drug Resistance and Treatment [Embedded Auto-Generated Subtitles]

NaN

Articles

Most Recent | Most Viewed | Most Downloaded

Circular RNAs modulate cancer drug resistance: advances and challenges

Open Access Review DOI: 10.20517/cdr.2024.195 27 Mar 2025
Views: Downloads:
Download PDF

Exosomal miR-92b-5p regulates N4BP1 to enhance PTEN mono-ubiquitination in doxorubicin-resistant AML

Open Access Original Article DOI: 10.20517/cdr.2024.140 27 Mar 2025
Views: Downloads:
Download PDF

Strategies to combat cancer drug resistance: focus on copper metabolism and cuproptosis

Open Access Review DOI: 10.20517/cdr.2025.41 26 Mar 2025
Views: Downloads:
Download PDF

Research advances in natural sesquiterpene lactones: overcoming cancer drug resistance through modulation of key signaling pathways

Open Access Review DOI: 10.20517/cdr.2024.178 23 Mar 2025
Views: Downloads:
Download PDF

Unraveling BRAF alterations: molecular insights to circumvent therapeutic resistance across cancer types

Open Access Original Article DOI: 10.20517/cdr.2024.213 23 Mar 2025
Views: Downloads:
Download PDF

Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system

Open Access Review DOI: 10.20517/cdr.2023.16 19 Jun 2023
Views: Downloads:
Download PDF

Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects

Open Access Review DOI: 10.20517/cdr.2022.136 28 Apr 2023
Views: Downloads:
Download PDF

Anti-BCMA novel therapies for multiple myeloma

Open Access Review DOI: 10.20517/cdr.2022.138 21 Mar 2023
Views: Downloads:
Download PDF

Topic: Role of Tumor Microenvironment in Cancer Drug Resistance

Submission Deadline: 19 May 2025

Published articles: 3

For Readers

Add your e-mail address to receive forthcoming Issues of this journal:

Articles Collection
The webinar is scheduled for early May as an extension of the special issue.
We warmly welcome your participation and contributions.
This initiative not only recognizes the dedication of women in academia but also demonstrates our commitment to enhancing the participation of female scientists in high-impact research.
In celebration of International Women’s Day, this special collection highlights groundbreaking research from 2023 - 2024, led by female first or corresponding authors in our journal.
Authors of Review and Research Articles published in 2023-2024 have a chance to win the Best Paper Award, celebrating groundbreaking contributions to the field of cancer drug resistance.
We are pleased to announce a media partnership with the EMBO | EMBL Symposium - The ageing genome: from mechanisms to disease.

Interview with Professor David A. Gewirtz: Exploring Breakthroughs in Cancer Drug Resistance and Treatment [Embedded Auto-Generated Subtitles]

NaN

Topic: Role of Tumor Microenvironment in Cancer Drug Resistance

Submission Deadline: 19 May 2025

Published articles: 3

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/